SCHEMBL714707

SCHEMBL714707

O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)O

nearest known ligand 0.82

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.82
ACLY P53396 2/20 0.42
ALDH1A1 P00352 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HDAC1 Q13547 2/20 0.34
HDAC7 Q8WUI4 2/20 0.34
HDAC8 Q9BY41 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
TSHR P16473 2/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4965015 1.00 THRB (0.82) THRBACLYALDH1A1L3MBTL1HDAC1
SCHEMBL714887 1.00 THRB (0.82) THRBACLYALDH1A1L3MBTL1HDAC1
SCHEMBL713583 1.00 THRB (0.82) THRBACLYALDH1A1L3MBTL1HDAC1
SCHEMBL517575 1.00 THRB (0.82) THRBACLYALDH1A1L3MBTL1HDAC1
SCHEMBL517814 1.00 THRB (0.82) THRBACLYALDH1A1L3MBTL1HDAC1
SCHEMBL8563271 1.00 THRB (0.82) THRBACLYALDH1A1L3MBTL1HDAC1
Fluoride SCHEMBL6261467 0.97 THRB (0.78) THRBACLYALDH1A1L3MBTL1HDAC1
SCHEMBL11776383 0.97 THRB (0.78) THRBACLYALDH1A1L3MBTL1HDAC1
Ammonia Solution, Strong SCHEMBL28638201 0.97 THRB (0.78) THRBACLYALDH1A1L3MBTL1HDAC1
Ammonia Solution, Strong SCHEMBL28644453 0.97 THRB (0.78) THRBACLYALDH1A1L3MBTL1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260116798-A1 EFFECTIVE TREATMENT OF CHLOROTRIFLUOROETHYLENE (CTFE) OLIGOMERS AND DERIVATIVES UNIV CALIFORNIA (US) 2026-04-30 US disclosed
CN-119569516-A B@PDA@Viton composite particle and preparation method thereof 西安近代化学研究所 2025-03-07 CN disclosed
US-20240291009-A1 METHOD FOR PURIFYING TREATMENT TARGET SOLUTION AGC Inc. (JP) 2024-08-29 US disclosed
EP-4417582-A1 METHOD FOR PURIFYING TREATMENT TARGET SOLUTION AGC Inc. (JP) 2024-08-21 EP disclosed
CN-118176168-A Method for purifying liquid to be treated AGC株式会社 2024-06-11 CN disclosed
US-20240116075-A1 SUBSTRATE, SELECTIVE FILM DEPOSITION METHOD, DEPOSITION FILM OF ORGANIC MATTER, AND ORGANIC MATTER CENTRAL GLASS COMPANY, LIMITED (JP) 2024-04-11 US disclosed
EP-4287240-A1 SUBSTRATE, SELECTIVE FILM DEPOSITION METHOD, DEPOSITION FILM OF ORGANIC MATTER, AND ORGANIC MATTER Central Glass Company, Limited (JP) 2023-12-06 EP disclosed
WO-2023063339-A1 METHOD FOR PURIFYING TREATMENT TARGET SOLUTION AGC株式会社 2023-04-20 WO disclosed
CN-111333499-B Process for producing fluorine-containing carboxylic acid 中蓝晨光化工研究设计院有限公司 2023-02-10 CN disclosed
WO-2023008248-A1 REACTIVE MATERIAL AND THIN FILM PRODUCTION METHOD 株式会社ADEKA 2023-02-02 WO disclosed
US-8288490-B2 Process for producing catalyst component for addition polymerization SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-16 US disclosed
US-8217340-B2 Mass spectrometry substrate and mass spectrometry method CANON KABUSHIKI KAISHA (JP) 2012-07-10 US disclosed
US-20120053306-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-01 US disclosed
US-20090266982-A1 MASS SPECTROMETRY SUBSTRATE AND MASS SPECTROMETRY METHOD CANON KABUSHIKI KAISHA (JP) 2009-10-29 US disclosed
EP-2112680-A2 Mass spectrometry substrate and mass spectrometry method CANON KABUSHIKI KAISHA (JP) 2009-10-28 EP disclosed
EP-0981655-B1 CHEMICAL VAPOUR DEPOSITION PRECURSORS QINETIQ LTD (GB) 2002-10-16 EP disclosed
US-6383669-B1 COMPRISING ZIRCONIUM COMPLEXES WITH A BETA-DIKETONATE AND ALKANOL GROUPS; ELECTRO-CERAMIC DEVICES THEREFROM; USE IN FERRO-ELECTRIC MEMORIES AND INFRA-RED DETECTORS; ZIRCONIUM DIISOPROPOXY BIS(TETRAMETHYLHEPTANEDIOATE) FOR EXAMPLE THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) 2002-05-07 US disclosed
EP-0981655-A2 CHEMICAL VAPOUR DEPOSITION PRECURSORS Secretary of State for Defence acting through his Defence Evaluation and Research Agency (GB) 2000-03-01 EP disclosed
WO-1998051837-A2 CHEMICAL VAPOUR DEPOSITION PRECURSORS SECRETARY OF STATE FOR DEFENCE ACTING THROUGH HIS DEFENCE EVALUATION AND RESEARCH AGENCY (GB) 1998-11-19 WO disclosed
US-4401829-A Process for the preparation of perfluorinated carboxylic acid fluorides HOECHST AKTIENGESELLSCHAFT (DE) 1983-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053306-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION PPOX, SOD1, AP1M1 THRB 4450/4885ACLY 473/4885ALDH1A1 1442/4885
US-20260116798-A1 EFFECTIVE TREATMENT OF CHLOROTRIFLUOROETHYLENE (CTFE) OLIGOMERS AND DERIVATIVES ALDOA, PFKFB2, MGAM THRB 1335/4885ACLY 129/4885ALDH1A1 739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.